USDA Behavior, Motivation & Nutrition Study
Examination of Metabolic Determinants of Behavior and Motivation in Obesity: Implication to the Development of New Strategies for Achieving Body Weight Health
1 other identifier
observational
40
1 country
1
Brief Summary
This study will be a cross-sectional study. The primary aim of this study is to compare the relationship between neurological function, metabolic measures and health-related behaviors between normal weight and overweight/obese perimenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 4, 2009
CompletedFirst Posted
Study publicly available on registry
February 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedSeptember 14, 2011
September 1, 2011
3.1 years
February 4, 2009
September 13, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between metabolic measures and health-related behaviors in normal weight and overweight/obese perimenopausal women.
3 months
Study Arms (1)
1
Eligibility Criteria
Community sample
You may qualify if:
- Body Mass index 18-39.9 kg/m2
- Peri-menopausal status by self-report
You may not qualify if:
- Pregnant
- Plan to become pregnant
- Breastfeeding in the last 6 months
- Multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease
- Menopause confirmed
- Unable to refrain from smoking for five hours (self-report)
- Unable to refrain from consuming alcohol for two days (self-report)
- Weight change \> 10 lbs in the preceding 6 months
- Chronic corticosteroid use
- Oral corticosteroids used more than twice in the last 12 months
- Hormonal contraceptives
- Antipsychotic, anti-anxiety and anti-depressant medications
- Beta adrenergic blockers
- Sibutramine, orlistat, phentermine, phendimetrazine, topiramate, zonisamide
- Immunosuppressants
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA, ARS, Western Human Nutrition Research Center
Davis, California, 95616, United States
Related Links
Biospecimen
Blood and saliva samples will be kept for future research purposes.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Laugero, PhD
USDA, ARS, Western Human Nutrition Research Center
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2009
First Posted
February 6, 2009
Study Start
May 1, 2008
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
September 14, 2011
Record last verified: 2011-09